美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

The Oncology Institute

6.52

+0.35005.67%

成交量：150.42萬

成交額：979.18萬

市值：6.64億

市盈率：-21.43

高：6.70

開：6.16

低：6.12

收：6.17

52周最高：7.05

52周最低：2.32

股本：1.02億

流通股本：8,860.13萬

量比：1.65

換手率：1.70%

股息：- -

股息率：- -

每股收益(TTM):-0.3042

每股收益(LYR):-0.5445

淨資產收益率：--

總資產收益率：-9.65%

市淨率：-26.67

市盈率(LYR):-11.97

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

The Oncology Institute

交易所：

NASDAQ

成立時間：

2007

員工人數：

641

公司地址：

18000 Studebaker Road,Suite 800,Cerritos,California,United States

官網：

http://www.starlingoncology.com

郵編：

90703

電話：

傳真：

- -

簡介：

Starling Oncology, Inc.是一家於2019年11月1日成立的特拉華州公司。該公司是一家領先的基於價值的腫瘤學公司，管理以社區為基礎的腫瘤學實踐，在美國15個市場和5個州的76個診所為患者提供服務。該公司以社區為基礎的腫瘤科診所配備了112名腫瘤科醫生和高級診所提供者。在這些診所中，有62家診所配備了101名醫務人員，這些人員受雇於其附屬的由醫生擁有的專業公司，稱為“TOI個人電腦”。該公司管理的診所提供一系列腫瘤醫學服務，包括醫生服務、內部輸液和藥房、臨床試驗服務、放射、創新項目，如門診血液製品輸血，以及全天候的患者支持。

董事

名稱

職位

Brad Hively

Vice Chairman of the Board

Daniel Virnich

Director, President and Chief Executive Officer

Anne McGeorge

Chair

Karen M. Johnson

Independent Director

Kimberly Tzoumakas

Independent Director

Mark L. Pacala

Independent Director

Mohit Kaushal

Independent Director

股東

名稱

職位

Daniel Virnich

Director, President and Chief Executive Officer

Robert Ross Carter

Chief Financial Officer and Principal Accounting Officer

Yale Podnos

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/STLN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"STLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":6.52,"timestamp":1789416000000,"preClose":6.17,"halted":0,"volume":1504205,"delay":0,"changeRate":0.05672609400324143,"floatShares":88601299,"shares":101916100,"eps":-0.304237,"marketStatus":"盤前交易","change":0.35,"latestTime":"09-15 08:47:31 EDT","open":6.16,"high":6.6974,"low":6.12,"amount":9791832.5849385,"amplitude":0.093582,"askPrice":6.57,"askSize":3,"bidPrice":6.34,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.304237,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":6.52,"postHourTrading":{"tag":"盘后","latestPrice":6.52,"preClose":6.52,"latestTime":"19:30 EDT","volume":21894,"amount":142745.57,"timestamp":1789428656686,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6492269378915352,"impliedVol":1.1836,"impliedVolPercentile":0.931},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","floatShares":88601299,"roa":"-9.65%","roe":"--","lyrEps":-0.544488,"volumeRatio":1.6492269378915352,"shares":101916100,"dividePrice":0,"high":6.6974,"amplitude":0.093582,"preClose":6.17,"low":6.12,"week52Low":2.32,"pbRate":"-26.67","psRate":"1.13","week52High":7.05,"institutionHeld":0,"latestPrice":6.52,"committee":-0.5,"eps":-0.304237,"divideRate":0,"volume":1504205,"delay":0,"ttmEps":-0.304237,"open":6.16,"prevYearClose":3.56,"prevWeekClose":6.17,"prevMonthClose":5.91,"prevQuarterClose":5.43,"fiveDayClose":5.93,"twentyDayClose":6.45,"sixtyDayClose":5.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"STLN","fiscalQuarterEnding":"2026/06","expectedEps":-0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-05-06","symbol":"STLN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778097600000,"name":null,"time":"盤後","dateTimestamp":1778040000000,"actualEps":null},{"market":"US","date":"2026-03-12","symbol":"STLN","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-11-13","symbol":"STLN","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"盤後","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-08-13","symbol":"STLN","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1783569600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STLN","date":"2026-09-14","current":-21.430661,"percent":0.571429,"low":-18.702266,"twenty":-17.98338,"median":-17.410518,"eighty":-16.669167,"high":-11.557791,"avg":-16.842027,"sd":1.937151,"marketCap":628822429},"quantilePoints":[{"date":"2026-08-07","current":-13.746861,"twenty":-12.626432,"median":-11.833524,"eighty":-11.695657,"marketCap":498914835},{"date":"2026-08-14","current":-17.579006,"twenty":-17.646402,"median":-17.298192,"eighty":-11.842715,"marketCap":637994879},{"date":"2026-08-21","current":-18.365288,"twenty":-18.045159,"median":-17.64921,"eighty":-12.999908,"marketCap":666531392},{"date":"2026-08-28","current":-17.803658,"twenty":-18.129404,"median":-17.719414,"eighty":-15.827113,"marketCap":646148169},{"date":"2026-09-04","current":-16.764643,"twenty":-18.045159,"median":-17.487741,"eighty":-16.646701,"marketCap":608439206},{"date":"2026-09-11","current":-17.410518,"twenty":-17.988996,"median":-17.494762,"eighty":-16.66355,"marketCap":631879913},{"date":"2026-09-14","current":-17.326273,"twenty":-17.98338,"median":-17.410518,"eighty":-16.669167,"marketCap":628822429}],"updateTime":1789476447826},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":661363343,"yearFounded":2007,"employeeNum":641,"address":"18000 Studebaker Road,Suite 800,Cerritos,California,United States","zipCode":"90703","officePhone":"562 735 3226","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.starlingoncology.com","stockEarnings":[{"period":"1week","weight":0.0995},{"period":"1month","weight":0.0109},{"period":"3month","weight":0.2784},{"period":"6month","weight":0.8111},{"period":"1year","weight":1.1377},{"period":"ytd","weight":0.8315}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Starling Oncology, Inc.是一家於2019年11月1日成立的特拉華州公司。該公司是一家領先的基於價值的腫瘤學公司，管理以社區為基礎的腫瘤學實踐，在美國15個市場和5個州的76個診所為患者提供服務。該公司以社區為基礎的腫瘤科診所配備了112名腫瘤科醫生和高級診所提供者。在這些診所中，有62家診所配備了101名醫務人員，這些人員受雇於其附屬的由醫生擁有的專業公司，稱為“TOI個人電腦”。該公司管理的診所提供一系列腫瘤醫學服務，包括醫生服務、內部輸液和藥房、臨床試驗服務、放射、創新項目，如門診血液製品輸血，以及全天候的患者支持。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.260474},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.061864},{"month":3,"riseRate":0.5,"avgChangeRate":-0.006328},{"month":4,"riseRate":0.666667,"avgChangeRate":0.162739},{"month":5,"riseRate":0.5,"avgChangeRate":-0.012259},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.058298},{"month":7,"riseRate":0.714286,"avgChangeRate":0.276469},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.003702},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.001085},{"month":10,"riseRate":0.5,"avgChangeRate":0.091691},{"month":11,"riseRate":0,"avgChangeRate":-0.319754},{"month":12,"riseRate":1,"avgChangeRate":0.32933}],"exchange":"NASDAQ","name":"The Oncology Institute","nameEN":"The Oncology Institute"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"STLN\",market:\"US\",,,undefined,":{"directors":[{"name":"Brad Hively","position":"Vice Chairman of the Board"},{"name":"Daniel Virnich","position":"Director, President and Chief Executive Officer"},{"name":"Anne McGeorge","position":"Chair"},{"name":"Karen M. Johnson","position":"Independent Director"},{"name":"Kimberly Tzoumakas","position":"Independent Director"},{"name":"Mark L. Pacala","position":"Independent Director"},{"name":"Mohit Kaushal","position":"Independent Director"}],"executives":[{"name":"Daniel Virnich","position":"Director, President and Chief Executive Officer"},{"name":"Robert Ross Carter","position":"Chief Financial Officer and Principal Accounting Officer"},{"name":"Yale Podnos","position":"Chief Medical Officer"}]}}}